Do you have a regulatory strategy to help your company prepare for the new European Medical Device Regulation (EU MDR)? With the May 2020 deadline right around the corner, a main area of focus for medical device companies will be transitioning to the new European regulation.

Today’s guest is Isabella Schmitt, regulatory affairs consultant with Proxima Clinical Research. Isabella joins Jon Speer in this episode to share what listeners need to do to prepare for EU MDR, despite the recently announced two-year delay of EUDAMED.

Some of the highlights of the show include:

- Why EU MDR? Effort to address uproar over ruptured implant devices with unknown materials that made some patients sick.

- What is EU MDR? The purpose is increased focus on safety and the entire lifecycle approach, not only pre-market approval (PMA).

- Compliant Equivalency: Isabella describes biological and technological factors, as well as data and test requirements for clinical use and support.

- Preparation - First Step: Assess general safety and performance requirements (GSPRs) via gap analysis of existing, needed, and publicly available data.

- Startup vs. Established Products/Companies: Understand compliance of GSPRs, intended use, description of device, standard of care, and alternative options.

- EUDAMED: Medical database with access to and reporting of clinical investigation information, post-market surveillance, universal device identifiers (UDIs).